Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.56 - $20.78 $622,458 - $953,885
45,904 New
45,904 $662,000
Q2 2023

Aug 02, 2023

BUY
$22.62 - $39.32 $3 Million - $5.22 Million
132,811 Added 379.57%
167,801 $4.27 Million
Q4 2022

Feb 01, 2023

SELL
$36.43 - $49.4 $768,673 - $1.04 Million
-21,100 Reduced 37.62%
34,990 $1.39 Million
Q3 2022

Nov 10, 2022

SELL
$40.66 - $53.03 $423,961 - $552,943
-10,427 Reduced 15.68%
56,090 $2.73 Million
Q2 2022

Aug 11, 2022

BUY
$40.85 - $77.67 $1.06 Million - $2.01 Million
25,837 Added 63.51%
66,517 $3.17 Million
Q1 2022

May 12, 2022

BUY
$59.95 - $92.06 $1.54 Million - $2.36 Million
25,684 Added 171.27%
40,680 $2.95 Million
Q4 2021

Feb 11, 2022

SELL
$81.07 - $121.29 $373,975 - $559,510
-4,613 Reduced 23.52%
14,996 $1.25 Million
Q3 2021

Nov 12, 2021

BUY
$101.99 - $166.36 $1.24 Million - $2.03 Million
12,207 Added 164.91%
19,609 $2.33 Million
Q2 2021

Aug 12, 2021

BUY
$141.6 - $179.06 $1.05 Million - $1.33 Million
7,402 New
7,402 $1.24 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.